CARDIAC INVOLVEMENT IN VIRAL DISEASES

View at publisher Summarise with VIRAT
Authors: Muhammed Akif Atlan
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Viral infections are recognized as a major cause of cardiac disease, particularly in pediatric populations, where they account for a significant proportion of myocarditis and dilated cardiomyopathy cases. Cardiac involvement in viral diseases arises from three primary mechanisms: direct viral cytotoxicity, immune-mediated myocardial injury, and thrombotic complications. These overlapping pathways contribute to heterogeneous clinical presentations ranging from subclinical disease to life-threatening arrhythmias, acute heart failure, cardiogenic shock, or sudden cardiac death. Among the most frequently implicated viruses are parvovirus B19, coxsackievirus B, adenoviruses, herpesviruses, and the recently emergent SARS-CoV-2, all of which have been strongly associated with myocarditis and progressive cardiomyopathy.Persistent viral infection and abnormal immune activation often lead to chronic inflammation, maladaptive cardiac remodeling, and eventual progression to dilated cardiomyopathy. Inflammatory mediators such as TNF-α, IL-6, and IL-1β play central roles in virus-induced cardiac dysfunction, while autoimmune mechanisms, including cross-reactivity against cardiac myosin, perpetuate long-term myocardial damage. Moreover, viral persistence within cardiac tissue, as demonstrated in enterovirus and parvovirus infections, is strongly linked to adverse outcomes.Diagnosis remains challenging. Endomyocardial biopsy continues to be regarded as the gold standard for identifying viral genomes and histopathological evidence of myocardial injury. However, advances in cardiac magnetic resonance imaging have greatly improved non-invasive diagnosis and disease monitoring, offering valuable prognostic insights. Novel molecular techniques, including polymerase chain reaction and next-generation sequencing, are also being increasingly applied to detect viral persistence and guide therapeutic decision-making.Management strategies currently emphasize supportive care, with optimization of heart failure therapy and arrhythmia control. Nonetheless, antiviral and immunomodulatory therapies, including interferon-beta and immunosuppressive regimens, are under investigation and may hold promise for selected patients with evidence of active viral replication or severe immune activation. Given the complexity of viral cardiac involvement, multidisciplinary collaboration among cardiologists, infectious disease specialists, intensivists, and pediatricians is essential to improve patient outcomes.This chapter provides a comprehensive review of epidemiology, risk factors, underlying mechanisms, major cardiotropic viruses, diagnostic tools, and therapeutic approaches in viral cardiac disease. Early recognition and timely intervention remain critical to reducing long-term morbidity and mortality.Keywords: Antiviral therapy; Cardiac involvement; Cardiomyopathy; Endomyocardial biopsy; Myocarditis; Pediatric cardiology; Viral diseases

Fields of Study & Subjects

Viral Infections and Immunology Research Cardiomyopathy and Myosin Studies Kawasaki Disease and Coronary Complications

Publication details

Journal / source
Turkiye Klinikleri eBooks
Pages
449–464
Publication date
1 January 2026
Language
EN
Document type
Book chapter